NASDAQ:BWAY Brainsway Q2 2025 Earnings Report $12.64 -0.36 (-2.77%) Closing price 04:00 PM EasternExtended Trading$12.64 0.00 (0.00%) As of 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast Brainsway EPS ResultsActual EPSN/AConsensus EPS $0.07Beat/MissN/AOne Year Ago EPSN/ABrainsway Revenue ResultsActual RevenueN/AExpected Revenue$12.34 millionBeat/MissN/AYoY Revenue GrowthN/ABrainsway Announcement DetailsQuarterQ2 2025Date8/5/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Brainsway Earnings HeadlinesStrength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength? - NasdaqJune 26, 2025 | nasdaq.comWall Street Analysts Believe Brainsway (BWAY) Could Rally 30.98%: Here's is How to Trade - NasdaqJune 26, 2025 | nasdaq.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. July 10 at 2:00 AM | Porter & Company (Ad)Brainsway Ltd. ADRJune 19, 2025 | marketwatch.comBrainsWay reports promising results for accelerated depression treatmentJune 12, 2025 | investing.comBrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)June 11, 2025 | globenewswire.comSee More Brainsway Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Brainsway? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Brainsway and other key companies, straight to your email. Email Address About BrainswayBrainsway (NASDAQ:BWAY) (NASDAQ: BWAY) is an Israeli medical device company headquartered in Jerusalem that specializes in designing, developing and marketing non-invasive neurostimulation technologies for the treatment of psychiatric and neurological disorders. Founded in 2003, the company’s core mission is to provide safe, drug-free alternatives for patients who have shown inadequate response to conventional therapies. The company’s flagship offering is the Deep Transcranial Magnetic Stimulation (Deep TMS) system, which utilizes patented H-coil technology to deliver magnetic pulses to specific brain regions. Deep TMS has received U.S. Food and Drug Administration clearances for treatment-resistant depression, obsessive-compulsive disorder and nicotine dependence. Beyond its approved indications, Brainsway is advancing a pipeline of coil configurations and treatment protocols targeting conditions such as anxiety, post-traumatic stress disorder and chronic pain. Brainsway maintains a global footprint, with direct sales operations and distribution partnerships across North America, Europe, Asia-Pacific and Israel. The company collaborates with leading academic institutions and clinical centers to conduct pivotal trials and expand the scientific evidence supporting its therapies. A dedicated network of clinical trainers and technical service teams ensures healthcare providers receive comprehensive support for implementing and maintaining Deep TMS systems in hospitals, outpatient clinics and specialized treatment centers. Since its initial public offering on the Nasdaq, Brainsway has steadily grown its installed base of Deep TMS systems while securing broader reimbursement coverage and forging strategic alliances. Under the leadership of Chief Executive Officer Ohad Tal and a management team with deep expertise in medical technology and neuroscience, Brainsway continues to invest in research and development. The company’s ongoing efforts focus on enhancing its existing product portfolio and exploring new applications for non-invasive brain stimulation in mental health and neurological care.Written by Jeffrey Neal JohnsonView Brainsway ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs Upcoming Earnings Bank of America (7/14/2025)America Movil (7/15/2025)Bank of New York Mellon (7/15/2025)BlackRock (7/15/2025)Citigroup (7/15/2025)JPMorgan Chase & Co. (7/15/2025)Progressive (7/15/2025)Charles Schwab (7/15/2025)UnitedHealth Group (7/15/2025)Wells Fargo & Company (7/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.